Skip to Content

TC3 (Toronto Cannabis and Cannabinoid Health Sciences Consortium)

The Toronto Cannabis and Cannabinoid Consortium (TC3) is a tri-campus, multi-institution, interdisciplinary Institutional Strategic Initiative that aims to advance cannabis and cannabinoid research across U of T and the Toronto Academic Health Sciences Network through research, education and training, resource sharing and collaboration, and knowledge translation and partnerships. The TC3 endeavours to close the significant gaps in knowledge related to the benefits, harms, and opportunities of cannabis and cannabinoid use and to develop a pipeline of highly qualified personnel who will become leaders in research and innovation in cannabis health sciences, business and policy. Together with our hospital partners, we are poised to take the lead as a cannabis knowledge creator and broker and make a national and international impact on health, policy and the economy.

8th Annual Cannabinoids in Clinical Practice

April 1, 2022 | 

The TC3 and the CCIC (Canadian Consortium for the Investigation of Cannabinoids) joined forces to co-host the 8th Annual Cannabinoids in Clinical Practice conference conference on April 21 - 22, 2022 at The Carlu in Toronto.

TC3 (Toronto Cannabis and Cannabinoid Health Sciences Consortium)

October 1, 2020 | 

The Toronto Cannabis and Cannabinoid Consortium (TC3) is a tri-campus, multi-institution, interdisciplinary Institutional Strategic Initiative that aims to advance cannabis and cannabinoid research across U of T and the Toronto Academic Health Sciences Network through research, education and training, resource sharing and collaboration, and knowledge translation and partnerships.  The TC3 endeavours to close the significant gaps in knowledge related to the benefits, harms, and opportunities of cannabis and cannabinoid use and to develop a pipeline of highly qualified personnel who will become leaders in research and innovation in cannabis health sciences, business and policy.  Together with our hospital partners, we are poised to take the lead as a cannabis knowledge creator and broker and make a national and international impact on health, policy and the economy.

Researchers from U of T, affiliated hospitals form research consortium to study risks and benefits of cannabis

April 9, 2019 | 

The Toronto Cannabis and Cannabinoid Research Consortium (TC3) was launched Thursday at a conference of researchers, government officials, policy-makers and industry representatives. TC3 combines the research muscle of the university with a dozen academic hospitals. “There is a huge research engine at U of T,” said Ruth Ross, a professor and chair of the Faculty of Medicine’s pharmacology and toxicology department and a member of the TC3 steering committee.

Cannabis Innovation Summit to officially launch U of T-led research consortium

April 3, 2019 | 

Researchers from UofT and its affiliated hospitals will meet this week at the Cannabis Innovation Summit to launch TC3 (Toronto Cannabis and Cannabinoid Research Consortium — a partnership focused on the health effects of cannabis and related compounds.
What are you searching for today?
magnifiercrosschevron-down